Literature DB >> 26696665

Comment on Erondu et al. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680-1686.

Ketan Dhatariya1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26696665     DOI: 10.2337/dc15-1956

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  1 in total

1.  Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.

Authors:  Jenny E Blau; Sri Harsha Tella; Simeon I Taylor; Kristina I Rother
Journal:  Diabetes Metab Res Rev       Date:  2017-09-29       Impact factor: 4.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.